Retracted: Second-Generation Tyrosine Kinase Inhibitor Discontinuation in Chronic Myeloid Leukemia Patients with Stable Deep Molecular Response: A Systematic Review and a Meta-Analysis

Detalles Bibliográficos
Autor principal: Methods in Medicine, Computational and Mathematical
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Retraction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10322427/
https://www.ncbi.nlm.nih.gov/pubmed/37416159
http://dx.doi.org/10.1155/2023/9789318
_version_ 1785068752647225344
author Methods in Medicine, Computational and Mathematical
author_facet Methods in Medicine, Computational and Mathematical
author_sort Methods in Medicine, Computational and Mathematical
collection PubMed
description
format Online
Article
Text
id pubmed-10322427
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-103224272023-07-06 Retracted: Second-Generation Tyrosine Kinase Inhibitor Discontinuation in Chronic Myeloid Leukemia Patients with Stable Deep Molecular Response: A Systematic Review and a Meta-Analysis Methods in Medicine, Computational and Mathematical Comput Math Methods Med Retraction Hindawi 2023-06-28 /pmc/articles/PMC10322427/ /pubmed/37416159 http://dx.doi.org/10.1155/2023/9789318 Text en Copyright © 2023 Computational and Mathematical Methods in Medicine. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Retraction
Methods in Medicine, Computational and Mathematical
Retracted: Second-Generation Tyrosine Kinase Inhibitor Discontinuation in Chronic Myeloid Leukemia Patients with Stable Deep Molecular Response: A Systematic Review and a Meta-Analysis
title Retracted: Second-Generation Tyrosine Kinase Inhibitor Discontinuation in Chronic Myeloid Leukemia Patients with Stable Deep Molecular Response: A Systematic Review and a Meta-Analysis
title_full Retracted: Second-Generation Tyrosine Kinase Inhibitor Discontinuation in Chronic Myeloid Leukemia Patients with Stable Deep Molecular Response: A Systematic Review and a Meta-Analysis
title_fullStr Retracted: Second-Generation Tyrosine Kinase Inhibitor Discontinuation in Chronic Myeloid Leukemia Patients with Stable Deep Molecular Response: A Systematic Review and a Meta-Analysis
title_full_unstemmed Retracted: Second-Generation Tyrosine Kinase Inhibitor Discontinuation in Chronic Myeloid Leukemia Patients with Stable Deep Molecular Response: A Systematic Review and a Meta-Analysis
title_short Retracted: Second-Generation Tyrosine Kinase Inhibitor Discontinuation in Chronic Myeloid Leukemia Patients with Stable Deep Molecular Response: A Systematic Review and a Meta-Analysis
title_sort retracted: second-generation tyrosine kinase inhibitor discontinuation in chronic myeloid leukemia patients with stable deep molecular response: a systematic review and a meta-analysis
topic Retraction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10322427/
https://www.ncbi.nlm.nih.gov/pubmed/37416159
http://dx.doi.org/10.1155/2023/9789318
work_keys_str_mv AT methodsinmedicinecomputationalandmathematical retractedsecondgenerationtyrosinekinaseinhibitordiscontinuationinchronicmyeloidleukemiapatientswithstabledeepmolecularresponseasystematicreviewandametaanalysis

Ejemplares similares